Skip to content
Welcome to Bio.News
We partnered with the Biotechnology Innovation Organization (BIO) in 2019 to develop comprehensive news content about the industry and a quick-read daily newsletter with […]
Welcome to Bio.News Read More »
Editors’ Choice
Venus Williams on tennis, health advocacy, and having ‘no limits’
Venus Williams has won seven Grand Slam singles titles, five at Wimbledon and two at the US Open. She’s also won four Olympic gold
Venus Williams on tennis, health advocacy, and having ‘no limits’ Read More »
Yes, we have a monkeypox vaccine – thanks to investment in medical preparedness
Since health officials confirmed the first recent case of monkeypox in a human on May 7, the virus has now spread to more than
Yes, we have a monkeypox vaccine – thanks to investment in medical preparedness Read More »
BIO expert: China pushes WTO IP waiver to gain tech access
The United States is the world leader in biotechnology, but the country wasn’t always on top, and there’s obviously no guarantee it will stay
BIO expert: China pushes WTO IP waiver to gain tech access Read More »
Clinical trial diversity is essential for equal access and good medicine
Clinical trial diversity is the cornerstone of equal access to care, but clinical trial participants are still overwhelmingly white. Data released by the Food
Clinical trial diversity is essential for equal access and good medicine Read More »
Looking back on the JOBS Act, 10 years later
April marked the 10-year anniversary of the JOBS (Jumpstart Our Business Startups) Act. The bill, which was signed into law thanks to bipartisan support
Looking back on the JOBS Act, 10 years later Read More »
FDA draft guidance on non-opioid analgesics ‘inadequate’
The opioid epidemic has hit the United States hard in the last 25 years, killing more than 70,000 in 2019 alone, according to the
FDA draft guidance on non-opioid analgesics ‘inadequate’ Read More »
Aduhelm decision will ‘chill’ innovation, say BIO experts
This month’s decision by the U.S. Centers for Medicare & Medicaid Services (CMS) to limit coverage of the Alzheimer’s drug Aduhelm to patients enrolled in
Aduhelm decision will ‘chill’ innovation, say BIO experts Read More »
Alnylam CEO Greenstreet: ‘You can go faster alone, but you go far together’
Bio.News interviewed Yvonne Greenstreet, who took the reins as CEO of Alnylam in January 2022, making her one of a small number of Black
Alnylam CEO Greenstreet: ‘You can go faster alone, but you go far together’ Read More »
I am BIO Podcast: What will COVID vaccine technology do next?
Science helped save the world from COVID. What will vaccine technology do next? Today’s new episode of the I am BIO Podcast explores this
I am BIO Podcast: What will COVID vaccine technology do next? Read More »